| HOME >> BIOLOGY >> TECHNOLOGY |
Net income $ 2,658 $ 1,990 $ 8,923 $ 6,822
Net income per
diluted share (1) $ 0.18 $ 0.14 $ 0.60 $ 0.48
Other information:
Shares to calculate
per share (1) 14,918 14,219 14,792 14,096
Depreciation &
amortization $ 914 $ 488 $ 2,584 $ 2,026
Interest expense 0 4 0 15
Gross margin
(% of sales) 50.3% 52.0% 52.0% 52.0%
Operating income
(% of sales) 15.8% 14.4% 17.7% 16.2%
Revenue increase
vs. FY 2007 19.6% 18.7%
Net income increase
vs. FY 2007 33.6% 30.8% NEOGEN CORPORATION UNAUDITED SUMMARIZED CONSOLIDATED BALANCE SHEET DATA
(In thousands)
Feb. 29 May 31
2008 2007
Assets
Current assets
Cash & investments $ 11,093 $ 13,424
Accounts receivable 18,107 14,914
Inventory 25,765 19,115
Other current assets 3,779 3,645
Total current assets 58,744 51,098
Property & equipment 16,547 16,402
Goodwill & other assets 44,527 37,784
Total assets $ 119,818 $ 105,284
Liabilities & Stockholders' Equity
Current liabilities $ 11,387 $ 10,038
Long-term l
'/>"/>
| SOURCE Neogen Corporation Copyright©2008 PR Newswire. All rights reserved |